Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Bangsberg

Showing results (1-10 of 416) with videos related to

Pageof 42
Sort By:
AIDS and Behavior|June 20, 2006
Monitoring adherence to HIV antiretroviral therapy in routine clinical practice: The past, the present, and the futureDavid R Bangsberg
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2006
Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppressionDavid R Bangsberg
Journal of Acquired Immune Deficiency Syndromes (1999)|January 29, 2008
The Achilles' heel of HIV treatment in resource-limited settingsDavid R Bangsberg
The Journal of Infectious Diseases|June 14, 2008
Preventing HIV antiretroviral resistance through better monitoring of treatment adherenceDavid R Bangsberg
Plos Medicine|May 23, 2008
A paradigm shift to prevent HIV drug resistanceDavid R Bangsberg
Current HIV/AIDS Reports|October 24, 2009
Modified directly observed therapy to improve HIV treatment outcomes: little impact with potent, once-daily therapy in unselected antiretroviral-naïve patientsDavid R Bangsberg
Current HIV/AIDS Reports|February 20, 2016
Cascade of Refusal-What Does It Mean for the Future of Treatment as Prevention in Sub-Saharan Africa?Ingrid T Katz, David R Bangsberg
Journal of General Internal Medicine|October 23, 2002
Is average adherence to HIV antiretroviral therapy enough?David R Bangsberg, Steven G Deeks
Annals of Internal Medicine|January 6, 2010
Spending more to save more: interventions to promote adherenceDavid R Bangsberg, Steven G Deeks
Journal of General Internal Medicine|September 1, 2011
The importance of social ties in sustaining medication adherence in resource-limited settingsAlexander C Tsai, David R Bangsberg
Pageof 42

Showing results (1-10 of 416) with videos related to

Sort By:
Pageof 42
AIDS and Behavior|June 20, 2006
Monitoring adherence to HIV antiretroviral therapy in routine clinical practice: The past, the present, and the futureDavid R Bangsberg
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 31, 2006
Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppressionDavid R Bangsberg
Journal of Acquired Immune Deficiency Syndromes (1999)|January 29, 2008
The Achilles' heel of HIV treatment in resource-limited settingsDavid R Bangsberg
The Journal of Infectious Diseases|June 14, 2008
Preventing HIV antiretroviral resistance through better monitoring of treatment adherenceDavid R Bangsberg
Plos Medicine|May 23, 2008
A paradigm shift to prevent HIV drug resistanceDavid R Bangsberg
Current HIV/AIDS Reports|October 24, 2009
Modified directly observed therapy to improve HIV treatment outcomes: little impact with potent, once-daily therapy in unselected antiretroviral-naïve patientsDavid R Bangsberg
Current HIV/AIDS Reports|February 20, 2016
Cascade of Refusal-What Does It Mean for the Future of Treatment as Prevention in Sub-Saharan Africa?Ingrid T Katz, David R Bangsberg
Journal of General Internal Medicine|October 23, 2002
Is average adherence to HIV antiretroviral therapy enough?David R Bangsberg, Steven G Deeks
Annals of Internal Medicine|January 6, 2010
Spending more to save more: interventions to promote adherenceDavid R Bangsberg, Steven G Deeks
Journal of General Internal Medicine|September 1, 2011
The importance of social ties in sustaining medication adherence in resource-limited settingsAlexander C Tsai, David R Bangsberg
Pageof 42